NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working.
|
|
3 new studies on CV disease that have received a lot of media attention but SHOULDNT change our practice – ENHANCE (ezetimibe); CORONA (rosuvastatin); ONTARGET (ACE/ARBs)
[podcast]http://www.npc.nhs.uk/podcast/NPCiPodcast_15thApril08.mp3[/podcast]
 |
Subscribe to the NPC podcast via the iTunes store |
 |
Subscribe to the NPC podcast via RSS feed |